ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists

Wang, Wenxin; Cao, Zhijun; Yang, Zhongcheng; Chen, Ya; Yao, Huixin; Zhou, Danting; Ou, Peixin; Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Lianru; Liu, Yuxia; Mao, Jianming; Xie, Jiayi; Xiang, Ruojing; Yang, Yuanqian; Chen, Yisi; Yang, Yonghong; Tan, Liyun; Tang, Haolong; Zhang, Luyong*; Li, Zheng*广东药学院; 1
European Journal of Medicinal Chemistry2023-10-5DOI: 10.1016/j.ejmech.2023.115614
10阅读
引用收藏
分享

摘要

Farnesoid X receptor (FXR) is considered as a promising target for the treatment of NASH. Although many nonsteroidal FXR agonists have been reported, the structure types are quite scarce and mainly limited to the isoxazole scaffold derived from GW4064. Therefore, it is crucial to expand the structure types of FXR agonist to explore wider chemical space. In this study, the structure-based scaffold hopping strategy was performed by hybrid FXR agonist 1 and T0901317, which resulted in the discovery of sulfonamide FXR agonist 19. Molecular docking study reasonably explained the SAR in this series, and compound 19 fitted well with the binding pocket in a similar mode to the co-crystal ligand. In addition, compound 19 exhibited considerable selectivity against other nuclear receptors. In NASH model, compound 19 alleviated the typical histological features of fatty liver, including steatosis, lobular inflammation, ballooning, and fibrosis. Moreover, compound 19 exhibited acceptable safety profiles with no acute toxicity to major organ. These results suggested that the novel sulfonamide FXR agonist 19 might be a promising agent for the treatment of NASH.

学科与关键词

关键词
FXRFibrosisModeling studySARNASH
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2023-10-05
卷期
第 258 卷
页码
115614
DOI
10.1016/j.ejmech.2023.115614
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Basic and Applied Basic Research of Guangzhou [202201010436]; National Key Clinical Specialty Construction Project (Clinical Pharmacy) in Guangdong Province; High-Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province; Special Fund of Science and Technology Innovation cultivation Project of Guangdong University students [pdjh2022a0262]; Innovation and Entrepreneurship Training program for College students [202110573005]

作者

  • W

    Wang, Wenxin (第一作者)

    guangdong pharmaceut univ

  • C

    Cao, Zhijun

    1 · guangdong pharmaceut univ

查看全部 22 位作者收起作者
  • Y

    Yang, Zhongcheng

    guangdong pharmaceut univ

  • C

    Chen, Ya

    guangdong pharmaceut univ · new · 1

  • Y

    Yao, Huixin

    guangdong pharmaceut univ

  • Z

    Zhou, Danting

    guangdong pharmaceut univ

  • O

    Ou, Peixin

    1 · guangdong pharmaceut univ

  • H

    Huang, Wanqiu

    guangdong pharmaceut univ · new · 1

  • J

    Jiao, Shixuan

    guangdong pharmaceut univ · new · 1

  • C

    Chen, Siliang

    guangdong pharmaceut univ

  • C

    Chen, Lianru

    guangdong pharmaceut univ

  • L

    Liu, Yuxia

    1 · guangdong pharmaceut univ

  • M

    Mao, Jianming

    guangdong pharmaceut univ

  • X

    Xie, Jiayi

    guangdong pharmaceut univ

  • X

    Xiang, Ruojing

    guangdong pharmaceut univ

  • Y

    Yang, Yuanqian

    guangdong pharmaceut univ

  • C

    Chen, Yisi

    guangdong pharmaceut univ

  • Y

    Yang, Yonghong

    guangdong pharmaceut univ

  • T

    Tan, Liyun

    guangdong pharmaceut univ

  • T

    Tang, Haolong

    guangdong pharmaceut univ

  • Z

    Zhang, Luyong (通讯)

    guangdong pharmaceut univ · new

  • L

    Li, Zheng (通讯)

    guangdong pharmaceut univ · new · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417